Development Level

Tbio 91 | 10,625
Tdark 40 | 7,003
Tchem 3 | 1,890

IMPC Phenotype

preweaning lethality, complete... 2 | 633
decreased CD11b-low dendritic ... 1 | 3
decreased grip strength 1 | 123
embryonic lethality prior to o... 1 | 148
increased CD11b-high dendritic... 1 | 5
increased grip strength 1 | 83
prenatal lethality prior to he... 1 | 64

Disease

ovarian cancer 59 | 8,491
lung cancer 41 | 4,473
Multiple myeloma 31 | 1,327
osteosarcoma 28 | 7,933
diabetes mellitus 27 | 1,663
Diamond-Blackfan anemia 25 | 30
intraductal papillary-mucinous neoplasm (IPMN) 24 | 3,289
medulloblastoma, large-cell 22 | 6,234
psoriasis 18 | 6,685
pancreatic ductal adenocarcinoma liver metastasis 17 | 1,795
sonic hedgehog group medulloblastoma 16 | 1,482
intraductal papillary-mucinous adenoma (IPMA) 15 | 2,956
Waldenstrons macroglobulinemia 14 | 764
acute myeloid leukemia 14 | 785
intraductal papillary-mucinous carcinoma (IPMC) 14 | 2,988
Anemia, Diamond-Blackfan 13 | 15
Breast cancer 12 | 3,098
atypical teratoid / rhabdoid tumor 12 | 4,369
colon cancer 11 | 1,475
cystic fibrosis 11 | 1,670
glioblastoma 11 | 5,572
Disease Progression 10 | 125
Mammary Neoplasms 10 | 410
Stomach Neoplasms 10 | 282
acute quadriplegic myopathy 10 | 1,157
malignant mesothelioma 10 | 3,163
non primary Sjogren syndrome sicca 10 | 840
non-small cell lung cancer 10 | 2,798
invasive ductal carcinoma 8 | 2,950
subependymal giant cell astrocytoma 8 | 2,287
Anemia 7 | 252
lung adenocarcinoma 7 | 2,714
oligodendroglioma 7 | 2,849
adult high grade glioma 6 | 2,148
astrocytoma 6 | 1,493
group 3 medulloblastoma 6 | 2,254
inflammatory breast cancer 6 | 404
mucosa-associated lymphoid tissue lymphoma 6 | 480
Cancer 5 | 2,346
astrocytic glioma 5 | 2,241
pediatric high grade glioma 5 | 2,712
Parkinson Disease 4 | 105
breast carcinoma 4 | 1,614
glioblastoma multiforme 4 | 347
pilocytic astrocytoma 4 | 3,086
posterior fossa group A ependymoma 4 | 1,511
primitive neuroectodermal tumor 4 | 3,031
Animal Mammary Neoplasms 3 | 135
Brain glioma 3 | 10
Duchenne muscular dystrophy 3 | 602
Irregular astigmatism 3 | 11
Mammary Neoplasms, Experimental 3 | 149
Polycystic Ovary Syndrome 3 | 334
Prostatic Neoplasms 3 | 471
Pure red-cell aplasia 3 | 4
Weight Gain 3 | 87
atypical teratoid/rhabdoid tumor 3 | 1,095
cutaneous lupus erythematosus 3 | 1,056
dermatomyositis 3 | 966
ependymoma 3 | 2,514
hereditary spastic paraplegia 3 | 313
lung carcinoma 3 | 2,844
nasopharyngeal carcinoma 3 | 1,056
ulcerative colitis 3 | 2,087
Acquired metabolic disease 2 | 267
Anoxia 2 | 33
Babesiosis 2 | 13
Bowen-Conradi syndrome 2 | 16
Brucellosis 2 | 24
Campylobacteriosis 2 | 12
Diamond-Blackfan Anemia With Microtia And Cleft Palate 2 | 3
Esophagus squamous cell carcinoma 2 | 3
Lymphoid leukemia 2 | 69
Melanotic neuroectodermal tumor 2 | 7
Mesenchymal chondrosarcoma 2 | 4
Neoplasm Invasiveness 2 | 127
Nonsyndromic deafness 2 | 121
Osteoporosis 2 | 259
Pick disease 2 | 1,893
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 | 18
Rheumatoid Arthritis 2 | 1,170
Sensorineural hearing loss 2 | 107
Shwachman-Diamond syndrome 2 | 16
Spondylolysis 2 | 9
Spondylosis 2 | 13
Theileriasis 2 | 13
Treacher Collins syndrome 2 | 29
Turner syndrome 2 | 31
Tyrosinemia type I 2 | 4
aldosterone-producing adenoma 2 | 664
group 4 medulloblastoma 2 | 1,875
juvenile dermatomyositis 2 | 1,189
medulloblastoma 2 | 1,524
non diabetic and post-ischemic heart failure 2 | 200
pancreatic cancer 2 | 2,300
primary pancreatic ductal adenocarcinoma 2 | 1,271
Hereditary Nonpolyposis Colorectal Cancer 1 | 13
Pasteurellosis 1 | 12
Phimosis 1 | 5
West Nile fever 1 | 6

Tissue

Blood and immune system 132 | 17,994
Cardiovascular System 132 | 17,957
Digestive Tract 132 | 18,472
Endocrine System 132 | 18,511
Female tissues 132 | 18,646
Liver and Pancreas 132 | 18,135
Male tissues 132 | 17,968
Nervous System 132 | 18,560
Respiratory system 132 | 17,483
Urinary Tract 132 | 18,443
Skin and soft tissues 129 | 18,114

Target Family

Non-IDG 134 | 11,969

KEGG Pathway

Ribosome 134 | 134
Metabolic pathways 1,254 | 1,254
Olfactory transduction 412 | 412
Pathways in cancer 402 | 402
HTLV-I infection 339 | 339
PI3K-Akt signaling pathway 338 | 338
Endocytosis 326 | 326
Epstein-Barr virus infection 279 | 279
Neuroactive ligand-receptor in... 276 | 276
Cytokine-cytokine receptor int... 262 | 262
Herpes simplex infection 262 | 262
MAPK signaling pathway 255 | 255
Viral carcinogenesis 253 | 253
Phagosome 231 | 231
Cell adhesion molecules (CAMs) 225 | 225
Ras signaling pathway 225 | 225
Rap1 signaling pathway 213 | 213
Regulation of actin cytoskelet... 213 | 213
Proteoglycans in cancer 202 | 202
cAMP signaling pathway 201 | 201
Focal adhesion 200 | 200
Natural killer cell mediated c... 199 | 199
Huntington's disease 194 | 194
Tuberculosis 187 | 187
Influenza A 184 | 184
Chemokine signaling pathway 182 | 182
Calcium signaling pathway 181 | 181
Axon guidance 176 | 176
Purine metabolism 171 | 171
Alzheimer's disease 169 | 169
Tight junction 169 | 169
NOD-like receptor signaling pa... 168 | 168
Protein processing in endoplas... 165 | 165
Transcriptional misregulation ... 165 | 165
cGMP-PKG signaling pathway 165 | 165
RNA transport 164 | 164
Oxytocin signaling pathway 158 | 158
Jak-STAT signaling pathway 157 | 157
Antigen processing and present... 156 | 156
Hippo signaling pathway 154 | 154
mTOR signaling pathway 153 | 153
Non-alcoholic fatty liver dise... 151 | 151
Adrenergic signaling in cardio... 150 | 150
MicroRNAs in cancer 150 | 150
Breast cancer 146 | 146
Alcoholism 145 | 145
Hepatitis B 145 | 145
Phospholipase D signaling path... 145 | 145
Parkinson's disease 142 | 142
Wnt signaling pathway 142 | 142
Signaling pathways regulating ... 141 | 141
Apoptosis 140 | 140
Insulin signaling pathway 138 | 138
Ubiquitin mediated proteolysis 137 | 137
Viral myocarditis 137 | 137
Measles 135 | 135
Oxidative phosphorylation 133 | 133
FoxO signaling pathway 132 | 132
Hepatitis C 132 | 132
Spliceosome 132 | 132
Dopaminergic synapse 131 | 131
Osteoclast differentiation 131 | 131
Autoimmune thyroid disease 130 | 130
Toxoplasmosis 130 | 130
Cell cycle 125 | 125
Platelet activation 124 | 124
AMPK signaling pathway 123 | 123
Lysosome 123 | 123
Type I diabetes mellitus 122 | 122
Vascular smooth muscle contrac... 121 | 121
Graft-versus-host disease 120 | 120
Sphingolipid signaling pathway 120 | 120
Neurotrophin signaling pathway 119 | 119
Oocyte meiosis 119 | 119
Th17 cell differentiation 119 | 119
Thyroid hormone signaling path... 118 | 118
Allograft rejection 116 | 116
Glutamatergic synapse 116 | 116
Leukocyte transendothelial mig... 116 | 116
Carbon metabolism 114 | 114
Serotonergic synapse 114 | 114
Cholinergic synapse 110 | 110
TNF signaling pathway 110 | 110
Insulin resistance 109 | 109
Hematopoietic cell lineage 108 | 108
Systemic lupus erythematosus 108 | 108
Chagas disease (American trypa... 106 | 106
T cell receptor signaling path... 104 | 104
Th1 and Th2 cell differentiati... 104 | 104
Glucagon signaling pathway 103 | 103
HIF-1 signaling pathway 103 | 103
Toll-like receptor signaling p... 103 | 103
Melanogenesis 102 | 102
Pyrimidine metabolism 102 | 102
AGE-RAGE signaling pathway in ... 101 | 101
Endocrine resistance 101 | 101
Estrogen signaling pathway 101 | 101
Retrograde endocannabinoid sig... 101 | 101
Amoebiasis 100 | 100
Rheumatoid arthritis 100 | 100

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
28S ribosomal protein S18a, mitochondrial MRPS18A Tdark Non-IDG 0.32 0.72 46
40S ribosomal protein S19 RPS19 Tbio Non-IDG -3.12258 1305.7 243
60S ribosomal protein L13a RPL13A Tbio Non-IDG -1.62587 63.2 46
40S ribosomal protein S7 RPS7 Tbio Non-IDG -1.83618 67.7 104
60S ribosomal protein L38 RPL38 Tdark Non-IDG -1.39373 24.2 45
40S ribosomal protein S21 RPS21 Tbio Non-IDG -1.89981 78.2 62
39S ribosomal protein L35, mitochondrial MRPL35 Tdark Non-IDG 0.00000 15
60S acidic ribosomal protein P1 RPLP1 Tbio Non-IDG -1.22833 29.8 76
60S acidic ribosomal protein P2 RPLP2 Tbio Non-IDG -2.23919 29.8 129
60S acidic ribosomal protein P0 RPLP0 Tbio Non-IDG -1.62553 58.5 171